Epic Sciences, a developer of diagnostic tests, has received a Phase II small business innovation research (SBIR) contract from the National Cancer Institute (NCI) and the National Institutes of Health (NIH) for the development of a lung ...
Tags: lung cancer diagnostic, blood test, Epic
Still got some money stashed away in a health-care flexible spending account? If so, you might want to put a trip to the pharmacy on your day's to-do list, or at least check your plan's paperwork to see if you can take advantage of the ...
Tags: health care, health care flexible spending, pharmacy, Medical
Volition has announced a new collaboration with the Wales Cancer Bank,with the two businesses set to carry out an internal clinical study for the Nucleosomics diagnostic products. At the end of this month,tests will be carried out on ...
Tags: Volition, Wales Cancer Bank, Nucleosomics diagnostic products
Accumetrics' VerifyNow II System has received CE marking for point-of-care measurement of platelet reactivity to antiplatelet agents. The receival of Ce mark is expected to expand the market opportunities for the VerifyNow System in both ...
Tags: Accumetrics, VerifyNow II System, CE marking, platelet reactivity
Nothing can sour a new pet-owner relationship like a shredded shoe or a chewed-up remote control. A dog's appetite for inedible objects can be exasperating and dangerous. Animal behavior consultant Arden Moore, author of "What Dogs Want: ...
Roche has announced the US launch of automated Elecsys HE4 assay, designed as an aid in monitoring the recurrence or progressive disease in patients with epithelial ovarian cancer. The assay, which is approved for use on the Elecsys ...
Tags: epithelial ovarian cancer, clinical technology, clinical trial
With SaaS (software-as-a-service) having become a preferred deployment model for new software purchases, customers should be entitled to a clear-cut set of rights and expectations from vendors, a new report from analyst firm Constellation ...
Tags: SaaS, software, analyst firm, software purchase
Agilent Technologies has signed an agreement to supply its nuclear magnetic resonance (NMR) components for use in LipoScience's automated Vantera Clinical Analyzer. The FDA-cleared Vantera Clinical Analyzer combines proprietary ...
Tags: Agilent, NMR, clinical technology, clinical application
The US Patent and Trademark Office (USPTO) will issue Patent No. 8,340,916 to Sequenom for its application covering methods of detecting fetal aneuploidy. The patent, which will be issued on 25 December 2012, covers claims related to ...
Tags: Sequenom, US patent, fetal aneuploidy, USPTO
Seegene has developed a new real-time multiplex quantification molecular diagnostic testing technology. The new technology is designed for the simultaneous detection and quantification of up to 20 analytes on an existing 4-channel ...
The US Court of Appeals for the Federal Circuit has upheld that the Myriad Genetics composition of matter claims covering isolated DNA of the BRCA 1 and BRCA 2 genes are patent-eligible material under Section 101 of the US Patent Act. ...
Tags: BRCA 1 genes, BRCA 2 genes, isolated DNA, Myriad Genetics
VelaDx has signed a license and supply agreement with Life Technologies to develop new sequencing-based in vitro diagnostic (IVD) tests on the Ion Personal Genome Machine (PGM) sequencer. Under the agreement, VelaDx will seek approvals ...
Tags: sequencing-based in vitro diagnostic tests, IVD tests, Ion PGM sequencer
Saladax Biomedical has received CE mark for its MyPaclitaxel and MyDocetaxel therapeutic dose management (TDM) MyCare assays, enabling commercialisation in the European Union (EU). Both paclitaxel and docetaxel are administered based on a ...
Tags: Saladax Biomedical, Saladax's MyCare technology platform, MyCare tests
Advanced Cell Diagnostics, a developer of cell- and tissue-based diagnostic tests for personalized medicine, has obtained $12m in Series B equity financing round. In the financing round, its existing investor, Morningside Ventures, and ...
Tags: Advanced Cell Diagnostics, cell-and tissue-based diagnostic tests
JS Genetics has launched a new proprietary buccal swab test, XCAT-KS, to diagnose Klinefelter syndrome (KS) and other male sex chromosome aneuploidies. XCAT-KS is a PCR / pyrosequencing based bloodless test which identifies KS and ...
Tags: clinical research, clinical technology, proprietary DNA diagnostic tests